ANDA 77298, held by Actavis Labs Fl Inc. Metoprolol Succinate.
As of Nov 16, 2026, ANDA 77298 (Metoprolol Succinate), held by Actavis Labs Fl Inc, was first approved by FDA on Apr 15, 2010, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 15, 2010 | Original application | Approved | None posted |
| Metoprolol SuccinateEQ 100MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Metoprolol SuccinateEQ 200MG TARTRATE · tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Jun 29, 2015 | Supplement 16Labeling · Standard review | Approved | None posted |
| May 31, 2013 | Supplement 1Labeling | Approved | None posted |
| Apr 15, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters